Assessment of Glial Activation Response in the Progress of Natural Scrapie after Chronic Dexamethasone Treatment

Neuroinflammation has been correlated with the progress of neurodegeneration in many neuropathologies. Although glial cells have traditionally been considered to be protective, the concept of them as neurotoxic cells has recently emerged. Thus, a major unsolved question is the exact role of astrogli...

Full description

Bibliographic Details
Main Authors: Isabel M. Guijarro, Moisés Garcés, Pol Andrés-Benito, Belén Marín, Alicia Otero, Tomás Barrio, Margarita Carmona, Isidro Ferrer, Juan J. Badiola, Marta Monzón
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/9/3231
_version_ 1797569010357764096
author Isabel M. Guijarro
Moisés Garcés
Pol Andrés-Benito
Belén Marín
Alicia Otero
Tomás Barrio
Margarita Carmona
Isidro Ferrer
Juan J. Badiola
Marta Monzón
author_facet Isabel M. Guijarro
Moisés Garcés
Pol Andrés-Benito
Belén Marín
Alicia Otero
Tomás Barrio
Margarita Carmona
Isidro Ferrer
Juan J. Badiola
Marta Monzón
author_sort Isabel M. Guijarro
collection DOAJ
description Neuroinflammation has been correlated with the progress of neurodegeneration in many neuropathologies. Although glial cells have traditionally been considered to be protective, the concept of them as neurotoxic cells has recently emerged. Thus, a major unsolved question is the exact role of astroglia and microglia in neurodegenerative disorders. On the other hand, it is well known that glucocorticoids are the first choice to regulate inflammation and, consequently, neuroglial inflammatory activity. The objective of this study was to determine how chronic dexamethasone treatment influences the host immune response and to characterize the beneficial or detrimental role of glial cells. To date, this has not been examined using a natural neurodegenerative model of scrapie. With this aim, immunohistochemical expression of glial markers, prion protein accumulation, histopathological lesions and clinical evolution were compared with those in a control group. The results demonstrated how the complex interaction between glial populations failed to compensate for brain damage in natural conditions, emphasizing the need for using natural models. Additionally, the data showed that modulation of neuroinflammation by anti-inflammatory drugs might become a research focus as a potential therapeutic target for prion diseases, similar to that considered previously for other neurodegenerative disorders classified as prion-like diseases.
first_indexed 2024-03-10T20:04:53Z
format Article
id doaj.art-ce54c59372664af6a64c00142aac4dfc
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T20:04:53Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-ce54c59372664af6a64c00142aac4dfc2023-11-19T23:21:44ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-05-01219323110.3390/ijms21093231Assessment of Glial Activation Response in the Progress of Natural Scrapie after Chronic Dexamethasone TreatmentIsabel M. Guijarro0Moisés Garcés1Pol Andrés-Benito2Belén Marín3Alicia Otero4Tomás Barrio5Margarita Carmona6Isidro Ferrer7Juan J. Badiola8Marta Monzón9Research Centre for Encephalopathies and Transmissible Emerging Diseases—Institute for Health Research Aragón (IIS), University of Zaragoza, C/Miguel Servet 155, 50013 Zaragoza, SpainResearch Centre for Encephalopathies and Transmissible Emerging Diseases—Institute for Health Research Aragón (IIS), University of Zaragoza, C/Miguel Servet 155, 50013 Zaragoza, SpainBellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, 08908 Barcelona, SpainResearch Centre for Encephalopathies and Transmissible Emerging Diseases—Institute for Health Research Aragón (IIS), University of Zaragoza, C/Miguel Servet 155, 50013 Zaragoza, SpainResearch Centre for Encephalopathies and Transmissible Emerging Diseases—Institute for Health Research Aragón (IIS), University of Zaragoza, C/Miguel Servet 155, 50013 Zaragoza, SpainResearch Centre for Encephalopathies and Transmissible Emerging Diseases—Institute for Health Research Aragón (IIS), University of Zaragoza, C/Miguel Servet 155, 50013 Zaragoza, SpainBellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, 08908 Barcelona, SpainBellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, 08908 Barcelona, SpainResearch Centre for Encephalopathies and Transmissible Emerging Diseases—Institute for Health Research Aragón (IIS), University of Zaragoza, C/Miguel Servet 155, 50013 Zaragoza, SpainResearch Centre for Encephalopathies and Transmissible Emerging Diseases—Institute for Health Research Aragón (IIS), University of Zaragoza, C/Miguel Servet 155, 50013 Zaragoza, SpainNeuroinflammation has been correlated with the progress of neurodegeneration in many neuropathologies. Although glial cells have traditionally been considered to be protective, the concept of them as neurotoxic cells has recently emerged. Thus, a major unsolved question is the exact role of astroglia and microglia in neurodegenerative disorders. On the other hand, it is well known that glucocorticoids are the first choice to regulate inflammation and, consequently, neuroglial inflammatory activity. The objective of this study was to determine how chronic dexamethasone treatment influences the host immune response and to characterize the beneficial or detrimental role of glial cells. To date, this has not been examined using a natural neurodegenerative model of scrapie. With this aim, immunohistochemical expression of glial markers, prion protein accumulation, histopathological lesions and clinical evolution were compared with those in a control group. The results demonstrated how the complex interaction between glial populations failed to compensate for brain damage in natural conditions, emphasizing the need for using natural models. Additionally, the data showed that modulation of neuroinflammation by anti-inflammatory drugs might become a research focus as a potential therapeutic target for prion diseases, similar to that considered previously for other neurodegenerative disorders classified as prion-like diseases.https://www.mdpi.com/1422-0067/21/9/3231scrapiedexamethasoneneuroinflammationastrocytesmicrogliaprion diseases
spellingShingle Isabel M. Guijarro
Moisés Garcés
Pol Andrés-Benito
Belén Marín
Alicia Otero
Tomás Barrio
Margarita Carmona
Isidro Ferrer
Juan J. Badiola
Marta Monzón
Assessment of Glial Activation Response in the Progress of Natural Scrapie after Chronic Dexamethasone Treatment
International Journal of Molecular Sciences
scrapie
dexamethasone
neuroinflammation
astrocytes
microglia
prion diseases
title Assessment of Glial Activation Response in the Progress of Natural Scrapie after Chronic Dexamethasone Treatment
title_full Assessment of Glial Activation Response in the Progress of Natural Scrapie after Chronic Dexamethasone Treatment
title_fullStr Assessment of Glial Activation Response in the Progress of Natural Scrapie after Chronic Dexamethasone Treatment
title_full_unstemmed Assessment of Glial Activation Response in the Progress of Natural Scrapie after Chronic Dexamethasone Treatment
title_short Assessment of Glial Activation Response in the Progress of Natural Scrapie after Chronic Dexamethasone Treatment
title_sort assessment of glial activation response in the progress of natural scrapie after chronic dexamethasone treatment
topic scrapie
dexamethasone
neuroinflammation
astrocytes
microglia
prion diseases
url https://www.mdpi.com/1422-0067/21/9/3231
work_keys_str_mv AT isabelmguijarro assessmentofglialactivationresponseintheprogressofnaturalscrapieafterchronicdexamethasonetreatment
AT moisesgarces assessmentofglialactivationresponseintheprogressofnaturalscrapieafterchronicdexamethasonetreatment
AT polandresbenito assessmentofglialactivationresponseintheprogressofnaturalscrapieafterchronicdexamethasonetreatment
AT belenmarin assessmentofglialactivationresponseintheprogressofnaturalscrapieafterchronicdexamethasonetreatment
AT aliciaotero assessmentofglialactivationresponseintheprogressofnaturalscrapieafterchronicdexamethasonetreatment
AT tomasbarrio assessmentofglialactivationresponseintheprogressofnaturalscrapieafterchronicdexamethasonetreatment
AT margaritacarmona assessmentofglialactivationresponseintheprogressofnaturalscrapieafterchronicdexamethasonetreatment
AT isidroferrer assessmentofglialactivationresponseintheprogressofnaturalscrapieafterchronicdexamethasonetreatment
AT juanjbadiola assessmentofglialactivationresponseintheprogressofnaturalscrapieafterchronicdexamethasonetreatment
AT martamonzon assessmentofglialactivationresponseintheprogressofnaturalscrapieafterchronicdexamethasonetreatment